浙江昂利康制药股份有限公司关于获得药品补充申请批准通知书的公告

Group 1 - Company received the drug supplement application approval notice for Domperidone tablets from the National Medical Products Administration, which is equivalent to passing the consistency evaluation and will enhance market competitiveness [1][2] - Domperidone tablets are indicated for dyspepsia, abdominal distension, belching, nausea, vomiting, and abdominal pain [1][5] Group 2 - The subsidiary, Zhejiang Anglikang Animal Health Technology Co., Ltd., obtained the approval number for "Inhalation Sevoflurane (for pets)" from the Ministry of Agriculture and Rural Affairs, indicating compliance with production and sales conditions [4][6] - The approval of the veterinary drug will enrich the company's product portfolio and positively impact the strategic layout for pet medications [6]